Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Unity Biotechnology Inc (UBX)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Unity Biotech's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.827 +0.049    +6.32%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
0.839
+0.012
+1.390%
19:23:26 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US91381U1016 
CUSIP:  91381U101
  • Volume: 260,883
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.780 - 0.840
Unity Biotech 0.827 +0.049 +6.32%

UBX Balance Sheet

 
Featured here, the Balance Sheet for Unity Biotechnology Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2022
31/03
 2021
31/12
 2021
30/09
 2021
30/06
Total Current Assets 81.48 90.5 84.73 87.61
Cash and Short Term Investments 79.16 88.08 80.97 83.94
Cash - - - -
Cash & Equivalents 16.45 32.91 21.99 13.5
Short Term Investments 62.72 55.17 58.97 70.44
Total Receivables, Net - - - -
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 1.77 1.88 3.21 3.67
Other Current Assets, Total 0.55 0.55 0.55 -
Total Assets 112.47 124.71 125.69 136.26
Property/Plant/Equipment, Total - Net 30.01 31.23 32.46 33.67
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - 1.99 7.5 13.54
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 0.97 0.99 1 1.45
Other Assets, Total - - - -
Total Current Liabilities 17.91 16.62 12.98 13.39
Accounts Payable 3.32 1.99 1.77 1.9
Payable/Accrued - - - -
Accrued Expenses 9.53 10.4 10.26 11.5
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 4.84 3.06 0.94 -
Other Current liabilities, Total 0.22 1.18 - -
Total Liabilities 61.78 65.14 67.95 70.35
Total Long Term Debt 14.53 18.41 24.14 24.89
Long Term Debt 14.53 18.41 24.14 24.89
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 29.34 30.12 30.84 32.06
Total Equity 50.69 59.57 57.74 65.92
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.01 0.01 0.01 0.01
Additional Paid-In Capital 469.8 459.63 447.06 438.79
Retained Earnings (Accumulated Deficit) -418.94 -400.02 -389.33 -372.88
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) -0.18 -0.04 0.01 0.01
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 112.47 124.71 125.69 136.26
Total Common Shares Outstanding 69.15 62.99 57.47 55.1
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

UBX Comments

Write your thoughts about Unity Biotechnology Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Eren Eren
Eren Eren Jan 28, 2022 9:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I will buy this for my grandchildren!
Reply
0 0
Report
Yuliya Tenbruinskyy
Yuliya Tenbruinskyy Jan 18, 2021 8:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If bezos and thiel are in, im in
Reply
8 0
Report
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jan 18, 2021 8:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
now my sweet Yuliya what please ? pozalusta ? to entry inside you or not to entry ? best regars., Panagiotakis to kalo paidi.!
Reply
0 0
Report
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jan 18, 2021 8:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
to entry in Unity or not to entry what do you think ? best regards., Panagiotakis.
Reply
0 1
Report
Shlomi Berg
Shlomi Berg Sep 15, 2020 2:40PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
15% up?
Reply
2 0
Report
Yin LeGrand
Yin LeGrand Sep 04, 2020 10:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I would be too beautiful if their drug candidates worked. Unfortunately, the data says otherwise. They still have a few in the pipeline, and some cash to burn. Eventually they will have to issue more shares or issue large debts (Powell to buy?).. So, expect 1-5$ range for a while.
Reply
0 0
Report
Luis Niev
Luis Niev Aug 21, 2020 3:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bad stock no future.😢😢
Reply
2 2
Report
luis Nieves
luis Nieves Aug 18, 2020 2:09PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
never...
Reply
0 0
Report
Gilles Nadon
Gilles Nadon Aug 17, 2020 5:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
will this go back up
Reply
0 0
Report
luis Nieves
luis Nieves Aug 17, 2020 11:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bear very fear
Reply
0 0
Report
Farry Hardianto
Farry Hardianto Aug 17, 2020 8:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.globenewswire.com/news-release/2020/08/17/2079116/0/en/UNITY-Biotechnology-Announces-12-week-data-from-UBX0101-Phase-2-Clinical-Study-in-Patients-with-Painful-Osteoarthritis-of-the-Knee.html
Reply
1 2
Report
MoneyManager MoneyManager
Money2Manage4U Aug 15, 2020 2:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
is it true that Jeff Bezos from Amanon  invested 300mln USD in this company ?
Reply
0 0
Report
tom abc
investingA Aug 15, 2020 2:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i think that he deed
Reply
1 0
Report
Ralph Lynch
Ralph Lynch Aug 15, 2020 2:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
tom abc https://www.cnbc.com/2018/08/29/jeff-bezos-backs-silicon-valley-scientist-working-on-a-cure-for-aging.html
Reply
0 0
Report
MoneyManager MoneyManager
Money2Manage4U Aug 15, 2020 2:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ralph Lynch is it worth to entry for short or for mid - long term period ?
Reply
0 0
Report
MoneyManager MoneyManager
Money2Manage4U Aug 15, 2020 2:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
tom abc is it worth to entry in this equity for short or for mid long term please ?
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email